Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development

SummaryThe rapid emergence of resistance to novel tuberculosis drugs, such as bedaquiline, is a key threat to the long-term effectiveness of novel regimens. Given that the introduction of these agents has enabled the introduction of an all-oral regimen for rifampicin-resistant and multidrug-resistan...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Lancet infectious diseases
Hauptverfasser:	Saluzzo, Francesca, MD, Yerlikaya, Seda, PhD, Dorman, Susan Elizabeth, MD, Eisenach, Kathleen, PhD, Farhat, Maha Reda, MD, Ismail, Nazir, FCPath, Lienhardt, Christian, PhD, Walker, Timothy M, Prof, Jones, Fatima, PhD, Yepes, Ana, PhD, Penn-Nicholson, Adam, PhD, Ruhwald, Morten, MD, Kana, Bavesh, PhD, Denkinger, Claudia Maria, MD, Cirillo, Daniela Maria, MD
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	2025
Schlagworte:	Infectious Disease
ISSN:	1473-3099
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!